Overview

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the safety and tolerability of dutogliptin over 52 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Phenomix
Collaborator:
Forest Laboratories
Treatments:
Metformin
Sitagliptin Phosphate